When the U.S. Food and Drug Administration mandated the folic acid fortification of enriched cereal grains in 1998, it was celebrated as one of the greatest triumphs of preventive medicine. By introducing this critical B-vitamin into daily dietary staples, the nationwide incidence of devastating neural tube defects such as spina bifida plummeted by roughly 35%.
Yet, for nearly three decades, a gaping regulatory omission quietly left millions of Americans behind. While the FDA mandated fortification for wheat and rice flours, it excluded corn masa flour — the staple grain underpinning traditional Hispanic diets. The consequences of this technocratic gap fell squarely along genetic and ethnic lines, resulting in a persistent, disproportionately high rate of preventable birth defects.
As a pathologist, my perspective on this issue is grounded not in political philosophy but in the cold realities of cellular biology, tissue requirements, and clinical laboratory data. When we look at this disparity under the microscope, we find that it is neither a failure of individual willpower nor a consequence of an isolated genetic pool. It is a predictable, severe gene-environment mismatch.
Roughly 20% to 25% of the Hispanic population carries two copies of the MTHFR C677T gene variant. This highly prevalent polymorphism reduces the body’s enzymatic efficiency in converting dietary folate into its active, bioavailable form. Carrying this variant is not a cellular guarantee of an NTD, but it drastically raises the biochemical threshold of folate a mother’s cells require to protect a developing fetus during the earliest days of gestation. When a population with a high genetic requirement for folate relies on a staple grain completely stripped of folate, an avoidable clinical crisis is engineered.
Faced with federal inertia, state capitals have stepped in with powerful, common-sense legislative solutions. California pioneered this effort with Assembly Bill 1830, authored by Assemblymember Dr. Joaquin Arambula (a physician who understands the raw clinical necessity of food-based intervention). Following California’s launch, Alabama passed its own mandate, heavily championed by Republican lawmakers who recognized that protecting the lives of unborn children from preventable birth defects transcends party lines. Just this month, New Jersey joined the movement as Sen. Majority Leader M. Teresa Ruiz successfully ushered the “Fortifying Corn Masa Act” into law.
Predictably, this momentum has sparked pushback. Critics aligning with “health autonomy” movements have decried these updates as government overreach, arguing instead that public health agencies should simply educate at-risk populations to eat more folate-rich whole foods.
I am a physician who has spent the past year championing “Food is Medicine” initiatives supportive of HHS “MAHA” measures along these lines expanding nutritional access to combat metabolic disease. I find the argument against fortifying corn maza profoundly short-sighted. It fundamentally ignores both human biochemistry and supply chain economics. First, natural food folates lack the structural stability and high bioavailability of synthetic folic acid required to efficiently override a severe genetic metabolic hurdle like the MTHFR variant. Second, telling an at-risk demographic to simply alter their baseline cultural diet is a passive, individualistic cop-out to a structural problem.
Furthermore, framing the completion of this 28-year-old framework as an unprecedented expansion of the “nanny state” is historically inaccurate and intellectually dishonest. For nearly three decades, American consumers of every political stripe have routinely consumed mandated folic acid in their morning cereal, sandwich bread, and white rice. Requiring the exact same manufacturing standard for corn masa is not an invasive regulatory expansion; it is the uniform, equitable application of an existing, remarkably safe public health standard. To oppose corn masa fortification while leaving wheat and rice mandates untouched is to implicitly accept that public health protections should depend on a community’s cultural diet.
YOUR $2,000 PHONE IS BEING SAFETY-TESTED WITH 1996 RADIATION SCIENCE
Addressing health through manufacturing standards does not infringe upon individual health choices or bodily autonomy. The marketplace naturally preserves options for those who wish to avoid synthetic additives. Just as consumers seeking unfortified wheat can freely opt for organic, whole-grain, or non-enriched alternatives, the corn masa market will continue to offer unfortified, specialty, and non-enriched heirloom varieties.
For the vast majority of consumers who rely on standard commercial masa, however, fortification offers automated, baseline protection. This is why organizations such as the March of Dimes have applauded these bills for their widespread, bipartisan support. Medicine must move away from purely reactive treatments and embrace systemic, preventive solutions. Correcting the corn masa mismatch is not government overreach — it is an act of long-overdue clinical equality, protecting the next generation at the cellular level.
Eric S. Wargotz, MD, FCAP is a practicing physician, a pathologist, President of MedChi (The Maryland State Medical Society), and recipient of the 2026 College of American Pathologists Public Service Award.